Who owns Carmell Therapeutics Corp - US?
- Ticker: CTCXW
- CUSIP Number: 142922111
Tip: Access positions for across all investors
Analyze quarterly positions in Carmell Therapeutics Corp - US with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Carmell Therapeutics Corp - US stock
Who bought or sold Carmell Therapeutics Corp - US this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
UBS O'Connor | 371k | $57k | 100% | Mar 2024 |
|
Balyasny Asset Management | 343k | $52k | 0% | Mar 2024 |
|
OZ Management | 228k | $39k | 0% | Mar 2024 |
|
Millennium Management | 190k | $29k | -19% | Mar 2024 |
|
Highbridge Capital Management | 182k | $28M | 0% | Mar 2024 |
|
Exos Asset Management | 130k | $17k | 100% | Mar 2024 |
|
Exos TFP Holdings | 130k | $30k | 0% | Dec 2023 |
|
Citadel Advisors | 99k | $15k | 100% | Mar 2024 |
|
CNH Partners | 86k | $13k | -11% | Mar 2024 |
|
Walleye Trading Advisors | 51k | $7.8k | 0% | Mar 2024 |
|
Cowen And Company | 25k | $3.8k | 0% | Mar 2024 |
|
Saba Capital Management | 20k | $3.3k | 0% | Mar 2024 |
|
Whitebox Advisors | 19k | $2.9k | 0% | Mar 2024 |
|
Clear Street | 13k | $2.0k | 1% | Mar 2024 |
|
Wolverine Asset Management | 9.4k | $1.4k | -12% | Mar 2024 |
|
Ancora Advisors | 2.8k | $471.120800 | 0% | Mar 2024 |
|
Bank of America Corporation | 100.00 | $13.000000 | 100% | Mar 2024 |
|
Who sold out of Carmell Therapeutics Corp - US?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Linden Advisors | Sep 2023 | 371k | $93M |
Flow Traders US | Dec 2023 | 20k | $4.0k |